Stock screenerAll disclosures →
EDGAR →
OMER
Conviction 43HealthcareScan · Mon, Aug 10, 2026OMER$13.63+2.83%
ResistanceSupportVol 14Insider sellVol MA14 1.56M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price13.63
Change+2.83%
Gap+0.42%
Rel volume1.40×
Avg volume1.49M
Avg $ vol16.83M
SMA 2011.25
SMA 5010.51
SMA 20011.12
Price vs 50+29.68%
Price vs 200+22.47%
MA stackmixed
50/200 cross—
Supertrendup · 11.21
RSI (14)71
MACD hist0.29
MACD cross—
Stoch %K / %D100 / 98
ADX (14)28
+DI / −DI32 / 15
RSI divergence—
MACD divergenceBullish
ATR %+5.24%
ADR %6.04%
52w high17.18
52w low4.03
From 52w high-20.67%
Above 52w low+238.09%
New 52w highNo
SqueezeOff
Bollinger width49.83%
%B0.92
Donchian pos99.78%
Donchian high13.64
Donchian low9.12
AVWAP (52w high)12.26
vs AVWAP high+11.17%
AVWAP (52w low)10.61
vs AVWAP low+28.36%
OBV trendUp
Chaikin MF (20)0.31
Today vs 20d1.40×
Avg vol (14d)1.56M
Avg vol (20d)1.49M
Avg $ vol (20d)16.83M
Market cap986.11M
RS 3m (vs SPY)-15.19%
RS 6m (vs SPY)+9.26%
RS line new highNo
Trend template6/8
Technical rank88.8
1 week+8.48%
1 month+32.54%
3 months-3.57%
6 months+21.33%
1 year+260.45%
YTD-16.82%
P/E-294.36
P/B-15.57
P/S13.36
P/FCF-8.49
EPS-0.0500
Div yield—
ROE5.29%
ROA-1.17%
Debt/Eq-2.12
Current3.03
EV/EBITDA-9.18
Gross margin—
Net margin-4.54%
Rev growth-33.98%
EPS growth97.86%
Price target33.00
Target upside142.20%
Analyst ratingBuy
Institutional51.77%
Ent. value1.12B
Revenue9.89M
Net income56.06M
Gross profit—
Free cash flow-116.16M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out72.38M
Employees175
ListedThu, Oct 8, 2009
Free float60.84M
Float %85.8%
Short interest15.09M
Days to cover11.8d
Short volume48.6%
Squeeze score77 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.24 vs −$0.40
Last surprise+40.0% beat
Setup gradeD
Conviction43 / 100
Pattern quality—
Tech rank88.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.77
Support8.20
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in OMER
No recent disclosed trades by Congress in OMER. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in OMER · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
HANISH ARNOLD C Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 15K | — | 2026-06-18 | 2026-06-22 |
Bumol Thomas F. Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 15K | — | 2026-06-18 | 2026-06-22 |
Cable Thomas J. Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 15K | — | 2026-06-18 | 2026-06-22 |
Perkinson Diana T. Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 15K | — | 2026-06-18 | 2026-06-22 |
Demopulos Peter A MD Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 15K | — | 2026-06-18 | 2026-06-22 |
Hood Leroy E. MD PhD Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 15K | — | 2026-06-18 | 2026-06-22 |
Shah Rajiv Director · Stock Option (Right to Buy) · 2026-06-18 | Grant | 15K | — | 2026-06-18 | 2026-06-22 |
Cable Thomas J. Director · Common Stock · 2026-05-22 | Exercise | 7.5K | $81K | 2026-05-22 | 2026-05-27 |
Cable Thomas J. Director · Common Stock · 2026-05-22 | Sell | 7.5K | $87K | 2026-05-22 | 2026-05-27 |
Cable Thomas J. Director · Stock Option (Right to Buy) · 2026-05-22 | Exercise | 7.5K | $0 | 2026-05-22 | 2026-05-27 |
SEC filings
EDGAR filings in OMER · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.